BEDSIDE CONTROL CARD, ABO compatibility (Serafol)
Valid Article
BEDSIDE CONTROL CARD, ABO (Serafol)
Definition
Test performed "at the patient's bedside" immediately prior to transfusion to verify ABO compatibility between the recipient blood and the unit to be transfused.
Specifications
Technical specifications
- Double plastic-coated card (105 x 73 mm) with dessicated reagents
- clones: Anti-A 003/ Anti-B 005
- 4 reaction zones: 2 anti-A and 2 anti-B
- 1 donor side and 1 recipient side
- Spots of dried monoclonal antibodies
Packaging & Labelling
Box of 50 control cards. Individual aluminium packaging per card
To be Ordered Separately
- Transparent adhesive foils: 1 per card (packaged by 100), ref. BG1713
- Mixing sticks: 4 per card (packaged by 100), ref BG1712
- 1 safety lancet per card
- 1 ampoule of physiological saline solution per card
Instructions for use
The ultimate pretransfusional control card allows preventing ABO incompatibility accidents resulting from blood unit or patient misidentification.
The control must be performed at the patient's bedside immediately prior to transfusion by the nurse or the medical doctor who performs the transfusion.
The ABO group of the recipient is verified from a capillary blood sample, and the one of the blood unit from a tubing segment.
This test is not a substitute for patient and donor ABO Rh D blood grouping or laboratory "cross-matching" test.
Keep the card in the patient's medical file after covering it with a transparent adhesive foil once it is dry.
Storage
- Store between 2 and 25ºC
- Do not freeze
- Shelf life: 2 years
- Guaranteed minimum remaining shelf life at delivery: 1/3 of the total shelf life
- Not to be used beyond expiry date
MSF requirements
Ultimate pretransfusional control using a bedside control card is compulsory.